Skip to main content

Table 2 Values of SIMCA and PLS-DA performances

From: Integrated plasma metabolomics and lipidomics profiling highlights distinctive signature of hepatocellular carcinoma in HCV patients

Method

Classes

SIMCA

PLS-DA

PCs

Sensitivity CV (%)

Specificity CV (%)

Sensitivity test (%)

Specificity test (%)

LVs

Sensitivity CV (%)

Specificity CV (%)

Sensitivity test (%)

Specificity test (%)

Lipidomics

HCC

4

91.84

70.92

100.00

66.67

3

93.88

100.00

85.00

88.89

MC

1

57.14

100.00

100.00

100.00

 

100.00

100.00

100.00

100.00

HCV

3

94.12

82.25

100.00

69.57

 

100.00

94.64

83.33

86.96

Metabolomics

HCC

5

83.67

50.00

95.00

33.33

2

93.88

95.83

100.00

100.00

MC

1

28.57

100.00

100.00

100.00

 

100.00

100.00

100.00

100.00

HCV

4

47.06

97.79

100.00

91.30

 

94.12

94.64

100.00

100.00

  1. It reports the values of sensitivity and specificity for both cross-validation (leave one out) and test sets
  2. PCs principal components, CV cross validation, LVs latent variables